Hyperacute rejection remains a major obstacle in lung xenotransplantation, driven by human antibodies targeting glycan structures on porcine endothelial cells.
The discovery of high-quality antibodies is critical for both research and therapeutic development. However, identifying rare antibody-secreting cells from B cell or hybridoma populations remains challenging, slowing the discovery process and increasing the risk of missing valuable antibody candidates.
Over the past decade, tissue-specific 3D cell culture has emerged as a promising alternative to animal testing—delivering human relevant data by better mimicking in vivo conditions such as cellular diversity, metabolism, and drug response.
The discovery of high-quality antibodies is critical for both research and therapeutic development. However, identifying rare antibody-secreting cells from B cell or hybridoma populations remains challenging, slowing the discovery process and increasing the risk of missing valuable antibody candidates.
Over the past decade, tissue-specific 3D cell culture has emerged as a promising alternative to animal testing—delivering human relevant data by better mimicking in vivo conditions such as cellular diversity, metabolism, and drug response.
Are you feeling the pressure of the time, effort, and costs involved in creating the perfect cell lines for your research? We’re excited to invite you to a live demonstration showcasing how CellRaftA microscale polystyrene growth surface within an array used to spatially segregate cells/colonies while maintaining shared media access, enabling imaging over time and targeted isolation. Technology is transforming cell line development workflows in labs worldwide.
Hyperacute rejection remains a major obstacle in lung xenotransplantation, driven by human antibodies targeting glycan structures on porcine endothelial cells.
The discovery of high-quality antibodies is critical for both research and therapeutic development. However, identifying rare antibody-secreting cells from B cell or hybridoma populations remains challenging, slowing the discovery process and increasing the risk of missing valuable antibody candidates.
Over the past decade, tissue-specific 3D cell culture has emerged as a promising alternative to animal testing—delivering human relevant data by better mimicking in vivo conditions such as cellular diversity, metabolism, and drug response.
The discovery of high-quality antibodies is critical for both research and therapeutic development. However, identifying rare antibody-secreting cells from B cell or hybridoma populations remains challenging, slowing the discovery process and increasing the risk of missing valuable antibody candidates.
Over the past decade, tissue-specific 3D cell culture has emerged as a promising alternative to animal testing—delivering human relevant data by better mimicking in vivo conditions such as cellular diversity, metabolism, and drug response.
Are you feeling the pressure of the time, effort, and costs involved in creating the perfect cell lines for your research? We’re excited to invite you to a live demonstration showcasing how CellRaft Technology is transforming cell line development workflows in labs worldwide.
